do guidelines recommend depression screening during pregnancy and after birth?
“Um we do have standard screening that's recommended during you know both during pregnancy for depression and um postpartum.”
a guest, an obstetrician (maternal-fetal medicine physician-scientist) said on The Peter Attia Drive, 2026-10-05, at 34:23. hear it in context →
first, the part that holds
the speaker is right. US guidelines recommend screening for depression both during pregnancy and after birth: the US Preventive Services Task Force does, obstetricians' and pediatricians' professional bodies have written guidance on it, and the task force's statement names pregnant and postpartum persons explicitly.
what we found when we went and looked
we read the 2023 US Preventive Services Task Force recommendation statement in JAMA. it says: "The USPSTF recommends screening for depression in the adult population, including pregnant and postpartum persons" (grade B, moderate certainty of moderate net benefit). the American College of Obstetricians and Gynecologists' 2023 Clinical Practice Guideline No. 4 covers perinatal screening, and the American Academy of Pediatrics' 2019 clinical report tells pediatric practices to screen for postpartum depression at the 1-, 2-, 4- and 6-month well-child visits. so the recommendation is real and comes from more than one body. delivery is another matter: CDC survey data from 2018 found that 20.9% of respondents who got prenatal care said no provider asked them about depression, and 12.6% said nobody asked at the postpartum visit.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| professional guidelines recommend depression screening during pregnancy | confirmed | the 2023 USPSTF statement in JAMA recommends depression screening in adults, "including pregnant and postpartum persons" (B grade). ACOG Clinical Practice Guideline No. 4 (Obstet Gynecol 2023;141(6):1232-1261) says in its abstract that it "includes recommendations on the screening and diagnosis of perinatal mental health conditions including depression." limitation: we read the ACOG abstract only. the full text, which sets the exact timing and evidence grades, is paywalled, so we don't quote it. [1][2] |
| professional guidelines recommend depression screening postpartum | confirmed | the USPSTF statement names postpartum persons. the 2019 AAP clinical report in Pediatrics goes further and tells pediatric practices to "establish a system to implement PPD screening at the 1-, 2-, 4-, and 6-month well-child visits", so the parent is also screened at the baby's checkups, not only at the obstetric postpartum visit. limitation: the USPSTF recommendation covers adults 19 and older. younger parents fall under separate adolescent guidance, which we did not check. [1][3] |
| this screening is 'standard', meaning patients reliably receive it | overstated | the speaker's words are about what is recommended, and on that they are right. if a listener takes 'standard' to mean it reliably happens, CDC PRAMS data (31 sites, 32,659 respondents, 2018 births) show 79.1% were asked about depression during prenatal care and 87.4% at the postpartum visit. that leaves about 1 in 5 not asked during pregnancy and 1 in 8 not asked postpartum. limitation: these numbers are self-reported, from before the 2023 guidance, and being asked about depression is not the same as a validated screening tool. [4] |
both directions
for the speaker: the national preventive-care body, the obstetric professional body and the pediatric professional body have each put perinatal depression screening into written guidance. the USPSTF names pregnant and postpartum persons in the recommendation itself, gives it a B grade, and concludes with moderate certainty that screening has a moderate net benefit. the pediatric guidance adds screening at four infant visits in the first six months. the claim, if anything, undersells how many bodies have said it.
against: a recommendation is not a guarantee. in the CDC's 2018 PRAMS data, about one in five people who received prenatal care did not report being asked about depression, and about one in eight were not asked at the postpartum visit. state rates varied widely. the USPSTF also limits its recommendation to depression: for suicide-risk screening in the same population, including pregnant and postpartum persons, it found the evidence insufficient (an I statement). screening alone is not treatment. the task force's B grade assumes the clinic has follow-up in place.
what this cannot say
we read the abstract of the ACOG screening guideline, not the full text, so we don't state its exact visit timing or evidence grades. the CDC figures are self-reported, cover 31 sites rather than the whole country, describe 2018 births (before the 2023 USPSTF and ACOG updates), and measure whether a provider asked about depression, not whether a validated instrument was used. the claim has no time limit and names no source, so we checked it against current US guidance only. we did not survey other countries' guidelines.
sources, each one fetched and read
- US Preventive Services Task Force. Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement. JAMA, 2023. PMID 37338872 What we read there: "The USPSTF recommends screening for depression in the adult population, including pregnant and postpartum persons" (B recommendation); screening for MDD in adults, including pregnant and postpartum persons, "has a moderate net benefit." Fetched 2026-10-06 (HTTP 203). https://pubmed.ncbi.nlm.nih.gov/37338872/
- American College of Obstetricians and Gynecologists. Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4. Obstetrics & Gynecology 2023;141(6):1232-1261. doi:10.1097/AOG.0000000000005200. PMID 37486660 What we read there: the guideline "includes recommendations on the screening and diagnosis of perinatal mental health conditions including depression"; "Recommendations are classified by strength and evidence quality." Fetched 2026-10-06 (HTTP 203). https://pubmed.ncbi.nlm.nih.gov/37486660/
- American Academy of Pediatrics clinical report. Incorporating Recognition and Management of Perinatal Depression Into Pediatric Practice. Pediatrics, 2019. PMID 30559120 What we read there: pediatric practices should "establish a system to implement PPD screening at the 1-, 2-, 4-, and 6-month well-child visits." Fetched 2026-10-06 (HTTP 203). https://pubmed.ncbi.nlm.nih.gov/30559120/
- Centers for Disease Control and Prevention. Vital Signs: Postpartum Depressive Symptoms and Provider Discussions About Perinatal Depression — United States, 2018. MMWR 2020;69(19):575-581 What we read there: 79.1% of respondents who received prenatal care reported being asked about depression; 87.4% reported being asked at the postpartum visit; postpartum depressive symptom prevalence 13.2%; PRAMS data, 31 sites, 32,659 respondents. Fetched 2026-10-06 (HTTP 200). https://www.cdc.gov/mmwr/volumes/69/wr/mm6919a2.htm
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam